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The sequence of the blaARI-1 gene from imipenem-resistant Acinetobacter baumannii 6B92 has been deter-
mined. The structural gene encodes a 273-amino-acid protein which is most related to the OXA class D
b-lactamases. The conserved S-T-F-K and K-T-G motifs were identified in the ARI-1 protein sequence, also
named OXA-23, but significantly, a point mutation (Y3F) was identified in the Y-G-N conserved motif, also
known to function in the active site.
Multiresistant Acinetobacter baumannii strains are now rec-
ognized as serious nosocomial pathogens (4, 5), and carbap-
enem-resistant strains are being reported increasingly (1, 3, 6,
11, 15, 18, 23). Imipenem-resistant A. baumannii 6B92 was
isolated from a patient in Edinburgh, United Kingdom, in 1985
(15). Imipenem resistance was attributed to a novel serine
b-lactamase, ARI-1 (15), and was subsequently demonstrated
to be transferable to Acinetobacter junii (18). Imipenem resis-
tance due to b-lactamases in A. baumannii has subsequently
been reported worldwide, and two additional b-lactamases,
ARI-2 (6) and an oxacillin-hydrolyzing enzyme (2, 11), defined
only by their biochemical properties, have been described. In
this paper we report the nucleotide and deduced amino acid
sequences of ARI-1 carried by the R plasmid pUK1356.
Bacterial strains and plasmids. The transconjugant A. junii
BD413-2(pUK1356) was used as the source of ARI-1. Esche-
richia coli TG2 {supE hsdD5 thi D(lac-proAB) D(slr-recA)
306::Tn10(tetr) F9[traD36 proAB1 lacIq lacZDM15]} (17) was
used as a host for recombinant plasmids prepared in the vector
pUC19 (24).
b-Lactamase purification and N-terminal amino acid se-
quencing. Cell extracts of A. junii BD413-2(pUK1356) were
loaded onto a Mono Q anion-exchange column (Pharmacia
Co. Ltd., Uppsala, Sweden) equilibrated with 50 mM Tris-HCl
(pH 8.2). Fractions were eluted with a gradient of 0 to 0.5 M
NaCl in 50 mM Tris-HCl (pH 8.2). The ARI-1 b-lactamase,
eluted in the unadsorbed fraction, was loaded onto a Super-
dex-75 gel filtration column (Pharmacia) equilibrated in 50
mM Tris-HCl (pH 7.5) containing 0.1 M NaCl. Fractions con-
taining b-lactamase activity, detected by an assay with nitroce-
fin (Glaxo Group Research Ltd., Greenford, United King-
dom), were concentrated by centrifugation using VectaSpin
microtube filters, with a molecular mass cutoff of 12 kDa
(Whatman International Ltd., Maidstone, United Kingdom).
Following native PAGE, ARI-1 was transferred to a Problot
membrane (PE Applied Biosystems, Warrington, United King-
dom), stained with Coomassie blue, and cut out for N-terminal
sequencing with a model 477A gas phase sequencer (PE Ap-
plied Biosystems). The 20 N-terminal amino acids were used to
prepare the degenerate oligonucleotide probe ARI-N (Table
1).
Restriction enzymes and DNA cloning. Restriction enzymes
(Life Technologies Ltd., Paisley, United Kingdom) were used
in accordance with the manufacturer’s instructions. Plasmid
pUK1356 was extracted, restricted, and cloned with the pro-
cedures described by Sambrook et al. (17). Recombinant
clones were selected on nutrient agar (IDG Ltd., Bury, United
Kingdom) containing X-Gal (5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside; 32.5 mg/liter), IPTG (isopropyl-b-D-thioga-
lactopyranoside; 7.8 mg/liter), and ampicillin (50 mg/liter;
Sigma Aldrich Co. Ltd., Poole, United Kingdom).
Hybridization and identification of the 5* end of the ARI-1
gene. Enhanced chemiluminescence probe labelling, hybridiza-
tion, and detection kits (Amersham Pharmacia Biotech UK
Ltd., Amersham, United Kingdom) were used in accordance
with the manufacturer’s instructions. A partial library of
pUK1356 recombinant clones was screened with an ARI-N
probe 39 end labelled with fluorescein-dUTP. Recombinant
plasmid from a single positive clone was purified with a Qiagen
(Crawley, United Kingdom) plasmid minikit and sequenced
with an ABI PRISM 377 automated DNA sequencer (PE Ap-
plied Biosystems). The sequence (Fig. 1, nucleotides 1 to 1345)
revealed 375 bp of the 59 end of the blaARI-1 gene.
PCR amplification and complete sequencing of the ARI-1
gene. PCRs were carried out in 100-ml volumes containing 16
mM (NH4)2SO4, 67 mM Tris-HCl (pH 8.8), 0.1% Tween 20
buffer, 2.5 mM MgCl2, 0.2 mM deoxynucleoside triphosphates
(Amersham Pharmacia Biotech UK Ltd.), 0.1 to 0.5 mM each
primer, and 1 U of BIOTAQ polymerase (Bioline UK Ltd.,
London, United Kingdom) or 1.25 U of Pfu DNA polymerase
(Promega UK Ltd., Southampton, United Kingdom). Tem-
plate DNA was boiled for 10 min before being added to the
reaction mixture. DNA amplification was performed in an
Omn-E thermal cycler (Hybaid Ltd., Teddington, United
Kingdom) under the following cycle conditions: 94°C for 5 min,
60°C for 1 min, 72°C for 2 min (one cycle); 94°C for 15 s, 60°C
for 1 min, 72°C for 2 min (30 cycles); and a final extension of
72°C for 5 min (one cycle). PCR products containing the 39 end
of the ARI-1 gene were obtained by inverse PCR of HincII or
Sau3A fragments of pUK1356 by using the primer pairs P1-P2
and Invrs2-Invrs3 (Table 1). PCR products comprising the
complete sequence of the blaARI-1 gene were generated by
using the primer pair P5-P6 (Table 1). The ARI-1 gene se-
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quence was determined from both strands with PCR products
from three independent reactions, at least one of which was
generated with Pfu DNA polymerase, being sequenced rou-
tinely.
Sequence data analysis, alignment, and phylogeny. For
computer analysis of sequence data, the software from the
BCM Search Launcher was used (21). The blaARI-1 gene com-
prises an 822-bp open reading frame, between the initiation
FIG. 1. Nucleotide and deduced amino acid sequences of the ARI-1 gene and the ARI-1 protein from A. baumannii 6B92. The boldface ATG and TAA represent
the initiation and termination codons, respectively. The b-lactamase active site S-T-F-K and the conserved motifs F-G-N and K-T-G are shown in boldface type. A
proposed cleavage site generating a possible signal sequence is indicated with a vertical arrow. Nucleotide sequence in italics shows .90% homology with the phaBAc
upstream region (19). } indicates the transcription start site identified by Schembri et al. (20). An imperfect inverted repeat sequence at the 39 end of the gene is shown
by a broken line, and possible cassette junctions are shown boxed.
TABLE 1. Oligonucleotides used in this study
Oligonucleotide
primera Application Sequence
b Positions in nucleotide
sequence shown in Fig. 1
ARI-N DNA hybridization 59-ACI GTI CAR CAY AAY YTI ATI AAY GA-39 1026–1051
P1 PCR and sequencing 59-TGA ACA ATC TGA CTC GGG CT-39 1072–1053 (complement)
P2 PCR and sequencing 59-TGG AGA ACC AGA AAA CGG AT-39 1240–1259
Invrs2 PCR and sequencing 59-TTT TGG AAA GAC TGG TTG GG-39 1610–1629
Invrs3 PCR and sequencing 59-CTG CTG TCC AAT TTC AGC AT-39 1451–1432 (complement)
Invrs1 Sequencing 59-TTT GCA TGA GAT CAA GAC CG-39 1404–1385 (complement)
P5 PCR and sequencing 59-AAG CAT GAT GAG CGC AAA G-39 785–803
P6 PCR and sequencing 59-AAA AGG CCC ATT TAT CTC AAA-39 1850–1830 (complement)
a All oligonucleotides were purchased from Life Technologies Ltd.
b I, inosine; R, any purine (A or G); Y, any pyrimidine (T or C).
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codon ATG (positions 972 to 974) and the stop codon TAA
(positions 1791 to 1793), which translates into a protein of 273
amino acids (Fig. 1) showing sequence homology to Ambler
class D (Bush group 2d) oxacillin-hydrolyzing enzymes. Some
unique features and distinct biochemical properties were
noted. Two highly conserved motifs, S-T-F-K and K-T-G (po-
sitions 79 to 82 and 216 to 218), believed to contribute to the
function of the serine active site (7, 12), were identified (Fig.
1). A third motif, F-G-N at positions 152 to 154, which differs
from the corresponding motif in all other OXA enzymes by the
presence of phenylalanine instead of tyrosine. This unique
substitution may have significant biochemical effects and is
possibly a factor in the evolution of carbapenem resistance in
this enzyme. A cladogram was constructed to relate ARI-1 to
18 other class D b-lactamases (Fig. 2). ARI-1 showed less than
40% identity with other OXA enzymes. Greatest identity was
observed with OXA-5 and OXA-10 (36% identity), 35% iden-
tity was observed with OXA-7 and OXA-11, and 32% identity
was observed with LCR-1 (8). ARI-1 is therefore a novel class
D b-lactamase and has been assigned the alternative name
OXA-23.
Analysis of the genetic environment of blaARI-1. The majority
of oxa genes are contained within mobile cassettes (13, 14, 16)
normally found inserted within integrons (10). The sequence
immediately upstream of the blaARI-1 structural gene did not
reveal cassette characteristics (i.e., consensus core sequence
GTTRRRY). Nevertheless, a large region of 944 bases show-
ing more than 90% homology with the phaBAc upstream region
previously identified in the chromosome and plasmids of Acin-
etobacter strains isolated from sludge (19) was found. Schembri
et al. (20) have shown a transcription start point within this
region (position 920 in Fig. 1). This may indicate that the
blaARI-1 gene has been specifically inserted downstream of an
active promoter, enabling low-level constitutive expression of
the gene in A. baumannii. Analysis of the region immediately
downstream of blaARI-1 revealed an imperfect inverted repeat
sequence with some of the characteristics of the 59-bp recom-
bination sites found in cassette structures (16). Although char-
acteristic of gene cassettes, it is possible that this sequence is
functioning as a transcription terminator sequence since there
was no evidence of an inverse core sequence (consensus se-
quence RYYYAAC). Furthermore, continuation of the pub-
lished pha operon sequence could not be identified. Despite
the apparent lack of evidence of an integron or cassette loca-
tion for the blaARI-1 gene, two GTTA sequences (boxed in Fig.
1) were identified and may define the ends of a potential novel
and unusual cassette structure.
Nucleotide sequence accession number. The nucleotide se-
quence data reported in this paper will appear in the EMBL
nucleotide database under accession no. AJ132105.
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